<DOC>
	<DOCNO>NCT00124150</DOCNO>
	<brief_summary>The IMASH trial simple , randomize , double-blinded , placebo-controlled , multi-center trial answer question : `` Does intravenous magnesium sulfate improve clinical outcome aneurysmal subarachnoid hemorrhage ? ''</brief_summary>
	<brief_title>Intravenous Magnesium Sulfate Aneurysmal Subarachnoid Haemorrhage ( IMASH )</brief_title>
	<detailed_description>Vasospasm worsen outcome patient aneurysmal subarachnoid hemorrhage ( ASAH ) . Magnesium known dilate cerebral artery block N-methyl-D-aspartate receptor injure neuron . Intravenous magnesium may prevent vasospasm subarachnoid hemorrhage may protect neuron damage establish vasospasm . The IMASH trial randomize , placebo-controlled , double-blinded , multi-center trial evaluate effect intravenous magnesium sulfate infusion clinical outcome patient aneurysmal subarachnoid haemorrhage . Methods : After obtain randomisation code : - Start MgSO4 20 mmol 30 minute , follow infusion 80 mmol/day equivalent volume saline within 48 h onset symptom , - Study drug infuse 14 day day hemorrhage ( regarded day 0 ) . - Measure plasma magnesium concentration daily perform transcranial Doppler monitor blood flow velocity middle cerebral artery extracranial segment internal carotid artery . - Plasma magnesium concentration IV MgSO4 group raise 2.0-2.5 mmol/L twice serum baseline level . Patients randomized saline infusion magnesium level normalize clinical indication . Outcome assessment Primary outcome : Extended Glasgow Outcome Scale six month Secondary outcome : Incidence clinical vasospasm , Barthel Index ; modify Rankin score , modify National Institute Health Stroke Score , MCA velocity , major complication Study duration : 6 year refine sample size 340 analysis pilot study data ; plan interim analysis .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<criteria>ASAH ( indicate CT scan lumbar puncture intracranial aneurysm confirm computer tomographic conventional angiography ) Within 48 hr ictus ( hemorrhage event ) Pregnancy Major renal , hepatic pulmonary disease Major cardiac disease recent myocardial infarct ( &lt; 6 month ) Age le 18 year Moribund condition admission ( define patient poor clinical condition active neurosurgical management would anticipate )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>subarachnoid hemorrhage</keyword>
	<keyword>magnesium sulfate</keyword>
</DOC>